Middle East Biobanks Market Size, Share & Trends Analysis Report By Product & Services, By Biospecimen (Human Tissues, Human Organs), By Biobanks (Real/Physical Biobanks, Virtual Biobanks), By Application, By Country, And Segment Forecasts, 2025 - 2033
Middle East Biobanks Market Summary
The Middle East biobanks market size was estimated at USD 0.884 billion in 2024 and is projected to reach USD 1.52 billion by 2033, growing at a CAGR of 6.34% from 2025 to 2033. This growth is driven by rising investments in precision medicine, increasing prevalence of chronic and genetic diseases, and government-led initiatives to strengthen healthcare infrastructure. Moreover, the region’s growing focus on genomic research, personalized therapies, and collaborations with international biobanking networks further accelerates market expansion.
Growth of Personalized Medicine and Genomics
The increasing adoption of personalized medicine and genomic research is a major factor driving the biobanks market in the Middle East. Precision medicine requires access to high-quality, patient-specific biological samples and corresponding clinical data to develop therapies tailored to individual genetic profiles. Biobanks are critical repositories that store these samples, enabling researchers and healthcare providers to study disease mechanisms, identify biomarkers, and design effective, targeted treatment strategies. The demand in the Middle East is particularly strong due to unique genetic variations and the high prevalence of inherited disorders, making region-specific biobank resources essential for therapeutic development and clinical research.
Middle East Biobanks Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East biobanks market report based on product & services, biospecimen, biobanks, application, and country.
The Middle East biobanks market size was estimated at USD 0.884 billion in 2024 and is projected to reach USD 1.52 billion by 2033, growing at a CAGR of 6.34% from 2025 to 2033. This growth is driven by rising investments in precision medicine, increasing prevalence of chronic and genetic diseases, and government-led initiatives to strengthen healthcare infrastructure. Moreover, the region’s growing focus on genomic research, personalized therapies, and collaborations with international biobanking networks further accelerates market expansion.
Growth of Personalized Medicine and Genomics
The increasing adoption of personalized medicine and genomic research is a major factor driving the biobanks market in the Middle East. Precision medicine requires access to high-quality, patient-specific biological samples and corresponding clinical data to develop therapies tailored to individual genetic profiles. Biobanks are critical repositories that store these samples, enabling researchers and healthcare providers to study disease mechanisms, identify biomarkers, and design effective, targeted treatment strategies. The demand in the Middle East is particularly strong due to unique genetic variations and the high prevalence of inherited disorders, making region-specific biobank resources essential for therapeutic development and clinical research.
Middle East Biobanks Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East biobanks market report based on product & services, biospecimen, biobanks, application, and country.
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Biobanking Consumables
- Laboratory Information Management Systems
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Biospecimen Outlook (Revenue, USD Million, 2021 - 2033)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Biobanks Outlook (Revenue, USD Million, 2021 - 2033)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Middle East
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
- Rest of Middle East
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Services
1.2.2. Biospecimen
1.2.3. Biobanks
1.2.4. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST BIOBANKS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growth of personalized medicine and genomics
3.2.1.2. Increasing R&D in biotechnology and pharmaceuticals
3.2.2. Market restraint analysis
3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.2. Sustainability challenges for biobanks
3.2.2.3. Other challenges in biobanking specimens for research
3.3. Middle East Biobanks Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. MIDDLE EAST BIOBANKS MARKET: PRODUCT & SERVICES ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Product & Services Market Share, 2024 & 2033
4.3. Product
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Biobank Equipment
4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.6.1. Biobanking & repository
4.6.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.2. Lab processing
4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.3. Qualification/ Validation
4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.4. Cold Chain Logistics
4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.5. Other Services
4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 5. MIDDLE EAST BIOBANKS MARKET: BIOSPECIMEN ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Biospecimen Market Share, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.3.1. Human Tissues
5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
5.3.2. Human Organs
5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3. Stem Cells
5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.2. Adult Stem Cells
5.3.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.3. Embryonic Stem Cells
5.3.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.4. IPS Cells
5.3.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.5. Other Stem Cells
5.3.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.4. Other biospecimens
5.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 6. MIDDLE EAST BIOBANKS MARKET: BIOBANKS ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Biobanks Market Share, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.3.1. Physical/Real biobanks
6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
6.3.1.2. Tissue Biobanks
6.3.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.3. Population based biobanks
6.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.4. Genetic (DNA/RNA)
6.3.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.5. Disease based biobanks
6.3.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Virtual biobanks
6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 7. MIDDLE EAST BIOBANKS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Application Market Share, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.3.1. Therapeutics
7.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.2. Drug discovery & clinical research
7.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.3. Clinical Diagnostics
7.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.4. Other Applications
7.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 8. MIDDLE EAST BIOBANKS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Country Market Dashboard
8.2. Country Market Share Analysis, 2024 & 2033
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. Middle East
8.4.1. Saudi Arabia
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. UAE
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Kuwait
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
8.4.4. Qatar
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
8.4.5. Oman
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
8.4.6. Rest of Middle East
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Qiagen
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Danaher Corporation
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Becton, Dickinson, and Company (BD)
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Taylor-Wharton
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Charles River Laboratories
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Lonza
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Stemcell Technologies
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Biovault Family
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Services
1.2.2. Biospecimen
1.2.3. Biobanks
1.2.4. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST BIOBANKS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growth of personalized medicine and genomics
3.2.1.2. Increasing R&D in biotechnology and pharmaceuticals
3.2.2. Market restraint analysis
3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.2. Sustainability challenges for biobanks
3.2.2.3. Other challenges in biobanking specimens for research
3.3. Middle East Biobanks Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. MIDDLE EAST BIOBANKS MARKET: PRODUCT & SERVICES ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Product & Services Market Share, 2024 & 2033
4.3. Product
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Biobank Equipment
4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.6.1. Biobanking & repository
4.6.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.2. Lab processing
4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.3. Qualification/ Validation
4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.4. Cold Chain Logistics
4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6.5. Other Services
4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 5. MIDDLE EAST BIOBANKS MARKET: BIOSPECIMEN ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Biospecimen Market Share, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.3.1. Human Tissues
5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
5.3.2. Human Organs
5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3. Stem Cells
5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.2. Adult Stem Cells
5.3.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.3. Embryonic Stem Cells
5.3.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.4. IPS Cells
5.3.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3.5. Other Stem Cells
5.3.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.4. Other biospecimens
5.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 6. MIDDLE EAST BIOBANKS MARKET: BIOBANKS ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Biobanks Market Share, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.3.1. Physical/Real biobanks
6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
6.3.1.2. Tissue Biobanks
6.3.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.3. Population based biobanks
6.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.4. Genetic (DNA/RNA)
6.3.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.1.5. Disease based biobanks
6.3.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Virtual biobanks
6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 7. MIDDLE EAST BIOBANKS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Application Market Share, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.3.1. Therapeutics
7.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.2. Drug discovery & clinical research
7.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.3. Clinical Diagnostics
7.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.3.4. Other Applications
7.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 8. MIDDLE EAST BIOBANKS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Country Market Dashboard
8.2. Country Market Share Analysis, 2024 & 2033
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. Middle East
8.4.1. Saudi Arabia
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. UAE
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Kuwait
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
8.4.4. Qatar
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
8.4.5. Oman
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
8.4.6. Rest of Middle East
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Qiagen
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Danaher Corporation
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Becton, Dickinson, and Company (BD)
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Taylor-Wharton
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Charles River Laboratories
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Lonza
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Stemcell Technologies
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Biovault Family
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 Middle East biobanks market, by country, 2021 - 2033 (USD Million)
Table 3 Middle East biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 4 Middle East biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 5 Middle East biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 6 Middle East biobanks market, by application, 2021 - 2033 (USD Million)
Table 7 Saudi Arabia biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 8 Saudi Arabia biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 9 Saudi Arabia biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 10 Saudi Arabia biobanks market, by application, 2021 - 2033 (USD Million)
Table 11 UAE biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 12 UAE biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 13 UAE biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 14 UAE biobanks market, by application, 2021 - 2033 (USD Million)
Table 15 Kuwait biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 16 Kuwait biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 17 Kuwait biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 18 Kuwait biobanks market, by application, 2021 - 2033 (USD Million)
Table 19 Qatar biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 20 Qatar biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 21 Qatar biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 22 Qatar biobanks market, by application, 2021 - 2033 (USD Million)
Table 23 Oman biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 24 Oman biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 25 Oman biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 26 Oman biobanks market, by application, 2021 - 2033 (USD Million)
Table 27 Rest of Middle East biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 28 Rest of Middle East biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 29 Rest of Middle East biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 30 Rest of Middle East biobanks market, by application, 2021 - 2033 (USD Million)
Table 1 List of abbreviations
Table 2 Middle East biobanks market, by country, 2021 - 2033 (USD Million)
Table 3 Middle East biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 4 Middle East biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 5 Middle East biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 6 Middle East biobanks market, by application, 2021 - 2033 (USD Million)
Table 7 Saudi Arabia biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 8 Saudi Arabia biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 9 Saudi Arabia biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 10 Saudi Arabia biobanks market, by application, 2021 - 2033 (USD Million)
Table 11 UAE biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 12 UAE biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 13 UAE biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 14 UAE biobanks market, by application, 2021 - 2033 (USD Million)
Table 15 Kuwait biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 16 Kuwait biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 17 Kuwait biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 18 Kuwait biobanks market, by application, 2021 - 2033 (USD Million)
Table 19 Qatar biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 20 Qatar biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 21 Qatar biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 22 Qatar biobanks market, by application, 2021 - 2033 (USD Million)
Table 23 Oman biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 24 Oman biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 25 Oman biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 26 Oman biobanks market, by application, 2021 - 2033 (USD Million)
Table 27 Rest of Middle East biobanks market, by product & services, 2021 - 2033 (USD Million)
Table 28 Rest of Middle East biobanks market, by biospecimen, 2021 - 2033 (USD Million)
Table 29 Rest of Middle East biobanks market, by biobanks, 2021 - 2033 (USD Million)
Table 30 Rest of Middle East biobanks market, by application, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Middle East Biobanks market: market outlook
Fig. 9 Middle East Biobanks competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Middle East Biobanks market driver impact
Fig. 15 Middle East Biobanks market restraint impact
Fig. 16 Middle East Biobanks market strategic initiatives analysis
Fig. 17 Middle East Biobanks market: Product & services movement analysis
Fig. 18 Middle East Biobanks market: Product & services outlook and key takeaways
Fig. 19 Product market estimates and forecast, 2021 - 2033
Fig. 20 Biobanking equipment market estimates and forecast, 2021 - 2033
Fig. 21 Temperature control systems estimates and forecast, 2021 - 2033
Fig. 22 Freezers & refrigerators market estimates and forecast, 2021 - 2033
Fig. 23 Cryogenic storage systems market estimates and forecast, 2021 - 2033
Fig. 24 Thawing equipment market estimates and forecast, 2021 - 2033
Fig. 25 Incubators & centrifuges market estimates and forecast, 2021 - 2033
Fig. 26 Alarms & monitoring systems market estimates and forecast, 2021 - 2033
Fig. 27 Accessories & other equipment market estimates and forecast, 2021 - 2033
Fig. 28 Biobanking consumables market estimates and forecast, 2021 - 2033
Fig. 29 Laboratory information management systems market estimates and forecast, 2021 - 2033
Fig. 30 Services market estimates and forecasts, 2021 - 2033
Fig. 31 Biobanking & repository market estimates and forecasts, 2021 - 2033
Fig. 32 Lab processing market estimates and forecasts,2021 - 2033
Fig. 33 Qualification/ Validation market estimates and forecasts,2021 - 2033
Fig. 34 Cold chain logistics market estimates and forecasts, 2021 - 2033
Fig. 35 Other services market estimates and forecasts,2021 - 2033
Fig. 36 Middle East Biobanks market: Biospecimen movement analysis
Fig. 37 Middle East Biobanks market: Biospecimen outlook and key takeaways
Fig. 38 Human tissues market estimates and forecasts, 2021 - 2033
Fig. 39 Human organs market estimates and forecasts,2021 - 2033
Fig. 40 Stem cells market estimates and forecasts, 2021 - 2033
Fig. 41 Adult stem cells market estimates and forecasts,2021 - 2033
Fig. 42 Embryonic stem cells market estimates and forecasts, 2021 - 2033
Fig. 43 IPS cells market estimates and forecasts, 2021 - 2033
Fig. 44 Other stem cells market estimates and forecasts, 2021 - 2033
Fig. 45 Other biospecimens market estimates and forecasts, 2021 - 2033
Fig. 46 Middle East Biobanks market: Biobanks movement analysis
Fig. 47 Middle East Biobanks market: Biobanks outlook and key takeaways
Fig. 48 Physical/Real biobanks market estimates and forecasts, 2021 - 2033
Fig. 49 Tissue biobanks market estimates and forecasts,2021 - 2033
Fig. 50 Population based biobanks market estimates and forecasts, 2021 - 2033
Fig. 51 Genetic (DNA/RNA) market estimates and forecasts,2021 - 2033
Fig. 52 Disease based biobanks market estimates and forecasts, 2021 - 2033
Fig. 53 Virtual biobanks market estimates and forecasts, 2021 - 2033
Fig. 54 Middle East Biobanks market: Application movement analysis
Fig. 55 Middle East Biobanks market: Application outlook and key takeaways
Fig. 56 Therapeutics market estimates and forecasts, 2021 - 2033
Fig. 57 Drug discovery & clinical research market estimates and forecasts,2021 - 2033
Fig. 58 Clinical diagnostics market estimates and forecasts, 2021 - 2033
Fig. 59 Other applications market estimates and forecasts,2021 - 2033
Fig. 60 Middle East Biobanks market: Country movement analysis
Fig. 61 Middle East Biobanks market: Country outlook and key takeaways
Fig. 62 Saudi Arabia country dynamics
Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033
Fig. 64 UAE country dynamics
Fig. 65 UAE market estimates and forecasts, 2021 - 2033
Fig. 66 Kuwait country dynamics
Fig. 67 Oman market estimates and forecasts, 2021 - 2033 Kuwait country dynamics
Fig. 68 Oman market estimates and forecasts, 2021 - 2033
Fig. 69 Qatar country dynamics
Fig. 70 Qatar market estimates and forecasts, 2021 - 2033
Fig. 71 Rest of Middle East country dynamics
Fig. 72 Rest of Middle East market estimates and forecasts, 2021 - 2033
Fig. 73 Market position of key market players- Middle East Biobanks market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Middle East Biobanks market: market outlook
Fig. 9 Middle East Biobanks competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Middle East Biobanks market driver impact
Fig. 15 Middle East Biobanks market restraint impact
Fig. 16 Middle East Biobanks market strategic initiatives analysis
Fig. 17 Middle East Biobanks market: Product & services movement analysis
Fig. 18 Middle East Biobanks market: Product & services outlook and key takeaways
Fig. 19 Product market estimates and forecast, 2021 - 2033
Fig. 20 Biobanking equipment market estimates and forecast, 2021 - 2033
Fig. 21 Temperature control systems estimates and forecast, 2021 - 2033
Fig. 22 Freezers & refrigerators market estimates and forecast, 2021 - 2033
Fig. 23 Cryogenic storage systems market estimates and forecast, 2021 - 2033
Fig. 24 Thawing equipment market estimates and forecast, 2021 - 2033
Fig. 25 Incubators & centrifuges market estimates and forecast, 2021 - 2033
Fig. 26 Alarms & monitoring systems market estimates and forecast, 2021 - 2033
Fig. 27 Accessories & other equipment market estimates and forecast, 2021 - 2033
Fig. 28 Biobanking consumables market estimates and forecast, 2021 - 2033
Fig. 29 Laboratory information management systems market estimates and forecast, 2021 - 2033
Fig. 30 Services market estimates and forecasts, 2021 - 2033
Fig. 31 Biobanking & repository market estimates and forecasts, 2021 - 2033
Fig. 32 Lab processing market estimates and forecasts,2021 - 2033
Fig. 33 Qualification/ Validation market estimates and forecasts,2021 - 2033
Fig. 34 Cold chain logistics market estimates and forecasts, 2021 - 2033
Fig. 35 Other services market estimates and forecasts,2021 - 2033
Fig. 36 Middle East Biobanks market: Biospecimen movement analysis
Fig. 37 Middle East Biobanks market: Biospecimen outlook and key takeaways
Fig. 38 Human tissues market estimates and forecasts, 2021 - 2033
Fig. 39 Human organs market estimates and forecasts,2021 - 2033
Fig. 40 Stem cells market estimates and forecasts, 2021 - 2033
Fig. 41 Adult stem cells market estimates and forecasts,2021 - 2033
Fig. 42 Embryonic stem cells market estimates and forecasts, 2021 - 2033
Fig. 43 IPS cells market estimates and forecasts, 2021 - 2033
Fig. 44 Other stem cells market estimates and forecasts, 2021 - 2033
Fig. 45 Other biospecimens market estimates and forecasts, 2021 - 2033
Fig. 46 Middle East Biobanks market: Biobanks movement analysis
Fig. 47 Middle East Biobanks market: Biobanks outlook and key takeaways
Fig. 48 Physical/Real biobanks market estimates and forecasts, 2021 - 2033
Fig. 49 Tissue biobanks market estimates and forecasts,2021 - 2033
Fig. 50 Population based biobanks market estimates and forecasts, 2021 - 2033
Fig. 51 Genetic (DNA/RNA) market estimates and forecasts,2021 - 2033
Fig. 52 Disease based biobanks market estimates and forecasts, 2021 - 2033
Fig. 53 Virtual biobanks market estimates and forecasts, 2021 - 2033
Fig. 54 Middle East Biobanks market: Application movement analysis
Fig. 55 Middle East Biobanks market: Application outlook and key takeaways
Fig. 56 Therapeutics market estimates and forecasts, 2021 - 2033
Fig. 57 Drug discovery & clinical research market estimates and forecasts,2021 - 2033
Fig. 58 Clinical diagnostics market estimates and forecasts, 2021 - 2033
Fig. 59 Other applications market estimates and forecasts,2021 - 2033
Fig. 60 Middle East Biobanks market: Country movement analysis
Fig. 61 Middle East Biobanks market: Country outlook and key takeaways
Fig. 62 Saudi Arabia country dynamics
Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033
Fig. 64 UAE country dynamics
Fig. 65 UAE market estimates and forecasts, 2021 - 2033
Fig. 66 Kuwait country dynamics
Fig. 67 Oman market estimates and forecasts, 2021 - 2033 Kuwait country dynamics
Fig. 68 Oman market estimates and forecasts, 2021 - 2033
Fig. 69 Qatar country dynamics
Fig. 70 Qatar market estimates and forecasts, 2021 - 2033
Fig. 71 Rest of Middle East country dynamics
Fig. 72 Rest of Middle East market estimates and forecasts, 2021 - 2033
Fig. 73 Market position of key market players- Middle East Biobanks market
